Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Study ID
NCT00002793

Study type
Interventional

Study phase
Phase 3

Study status
Unknown status

Trial Acronym

Trial Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug or giving the drugs in different ways may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy administered via an implantable pump with a subcutaneous port for unresectable liver metastases in patients with resected primary colorectal cancer.

More informations

Trial Starting Date

Jan 31,1991

Requirements

Gender All
Minimum age 18 Years
Maximum age 76 Years

Enrollement Limit

336